Primary Care

Survivorship   

Questions discussed in this category


Do you feel differently about using these in patients with a history of HR-negative breast cancer?

Patients in their later 40s with favorable intermediate-risk prostate cancer s/p 7000cGy/28 EBRT only.

How is your approach different from or similar to those who undergo surgical menopause? 

Are there specific vaccines you recommend repeating, or do you recommend a catch-up schedule?


Papers discussed in this category


Curr Oncol Rep,

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014-08-10

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006-02-01

Obstet Gynecol, 1998 Oct

Acta Oncol, 2019 Apr 08

Scandinavian journal of urology and nephrology, 2004

BJU international, 2005-10

Andrologia, 2017-02

Current opinion in urology, 2007 Nov

JAMA,

JAMA oncology, 2024 Jan 01